The firm has been dealing in Active Pharmaceutical Ingredients (APIs) since 1972 as part of its specialized focus on the niche market. APIs are exported to Brazil, Argentina, Germany, Switzerland, Korea, USA and Egypt among other countries. Select APIs are awaiting registration to be sold in the European Union and in Belarus.

As a part of its strategy to widen its presence in the API segment, Jagsonpal has plans to offer products like Allylestonol and Nandralone.

The following are the APIs presently available through Jagsonpal -